Maurice Horsten
Profile
Maurice Horsten has been Chief Executive Officer of PharmaCell BV since August, 2007.
Mr. Horsten is Founder of HulpmiddelenDirect.
He joined Eli Lilly & Co. in 1995 and held various marketing and sales management positions.
Prior to joining PharmaCell in 2006, he was Managing Director and a Co-Owner of Diabetes Direct BV.
Mr. Horsten received a Master's degree in Economics and Business Administration from the Maastricht University of the Netherlands.
Former positions of Maurice Horsten
| Companies | Position | End |
|---|---|---|
Diabetes Direct BV
 Diabetes Direct BV Drugstore ChainsRetail Trade Part of Mediq BV, Diabetes Direct BV is a Dutch company that distributes diabetes drugs. The company is based in 's-Hertogenbosch, Netherlands. Diabetes Direct was acquired by Mediq BV (OLD) on February 02, 2006. | Corporate Officer/Principal | - |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
PharmaCell BV
 PharmaCell BV BiotechnologyHealth Technology PharmaCell BV manufactures cell therapy and regenerative medicine. The firm engages in human cell line development and manufacturing of bio pharmaceuticals. Its services include process research and development, project management, incoming logistics, incoming goods, manufacturing auto logous and allogeneic products, quality control, final formulation, release and outgoing logistics. The company was founded by René Lardenoije and Jan Thio in 2005 and is headquartered in Maastricht, the Netherlands. | President | - |
Training of Maurice Horsten
| Maastricht University | Graduate Degree |
Experiences
Positions held
Linked companies
| Listed companies | 1 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| Private companies | 2 |
|---|---|
Diabetes Direct BV
Diabetes Direct BV Drugstore ChainsRetail Trade Part of Mediq BV, Diabetes Direct BV is a Dutch company that distributes diabetes drugs. The company is based in 's-Hertogenbosch, Netherlands. Diabetes Direct was acquired by Mediq BV (OLD) on February 02, 2006. | Retail Trade |
PharmaCell BV
PharmaCell BV BiotechnologyHealth Technology PharmaCell BV manufactures cell therapy and regenerative medicine. The firm engages in human cell line development and manufacturing of bio pharmaceuticals. Its services include process research and development, project management, incoming logistics, incoming goods, manufacturing auto logous and allogeneic products, quality control, final formulation, release and outgoing logistics. The company was founded by René Lardenoije and Jan Thio in 2005 and is headquartered in Maastricht, the Netherlands. | Health Technology |
- Stock Market
- Insiders
- Maurice Horsten
